| Meredith Watson, OT | |
|
1506 N Mckenzie St Ste 109, Foley, AL 36535-2264 | |
| (251) 923-5590 | |
| (251) 923-5592 |
| Full Name | Meredith Watson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 5 Years |
| Location | 1506 N Mckenzie St Ste 109, Foley, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285379230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5214 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benchmark Physical Therapy Of Alabama, Llc | 5698930444 | 74 |
News Archive
Adolor Corporation today reported net sales of ENTEREG® (alvimopan) were $7.5 million for the three months ended March 31, 2011, a 42% increase compared to net sales of $5.3 million for the three months ended March 31, 2010.
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B or hepatitis C experienced poor outcomes.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.
› Verified 1 days ago
| Provider Name | Agilitas Usa Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1962417444 PECOS PAC ID: 3375454648 Enrollment ID: O20120523000672 |
News Archive
Adolor Corporation today reported net sales of ENTEREG® (alvimopan) were $7.5 million for the three months ended March 31, 2011, a 42% increase compared to net sales of $5.3 million for the three months ended March 31, 2010.
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B or hepatitis C experienced poor outcomes.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.
› Verified 1 days ago
| Provider Name | Benchmark Physical Therapy Of Alabama, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659642916 PECOS PAC ID: 5698930444 Enrollment ID: O20120629000400 |
News Archive
Adolor Corporation today reported net sales of ENTEREG® (alvimopan) were $7.5 million for the three months ended March 31, 2011, a 42% increase compared to net sales of $5.3 million for the three months ended March 31, 2010.
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B or hepatitis C experienced poor outcomes.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Watson, OT 1200 Corporate Dr Ste 400, Hoover, AL 35242-5424 Ph: (423) 238-7217 | Meredith Watson, OT 1506 N Mckenzie St Ste 109, Foley, AL 36535-2264 Ph: (251) 923-5590 |
News Archive
Adolor Corporation today reported net sales of ENTEREG® (alvimopan) were $7.5 million for the three months ended March 31, 2011, a 42% increase compared to net sales of $5.3 million for the three months ended March 31, 2010.
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B or hepatitis C experienced poor outcomes.
Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects.
BioMedix Vascular Solutions, Inc. announced today that the company has partnered with Howard University Hospital, Department of Surgery to participate in a Community Health Project and Demonstration focused on diagnosing and treating the potentially life-threatening condition called Peripheral Arterial Disease (PAD).
A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.
› Verified 1 days ago
Foley Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 316 S Mckenzie St Ste 101, Foley, AL 36535 Phone: 251-978-1280 Fax: 251-970-3233 | |
Coastal Hand Therapy, Pc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 317 S Mckenzie St, Foley, AL 36535 Phone: 251-943-0441 Fax: 251-943-0441 | |
Gabrielle Ringler, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 12456 Sandy Ln, Foley, AL 36535 Phone: 251-533-4654 Fax: 800-721-2101 | |
Clay Smitherman, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 1701 N Alston St, Foley, AL 36535 Phone: 251-943-2781 | |
Tg Tregre, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Elecia Ln, Foley, AL 36535 Phone: 251-971-1436 | |
Mary Coleman, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 21040 Miflin Rd, Foley, AL 36535 Phone: 251-923-0888 |